Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Choriogonadotropin Alfa · Ovidrel, Pregnyl

Recombinant protein · Agonist of Luteinizing hormone/choriogonadotropin receptor (LHCGR) · developed by Organon Usa Llc

Approved FDA, Oct 1976
OGN Developer

What is Choriogonadotropin Alfa?

Choriogonadotropin alfa is a recombinant form of human chorionic gonadotropin (hCG) that acts as an agonist at the luteinizing hormone/choriogonadotropin receptor. It is used to induce final follicular maturation and ovulation in infertile women, and in the Pregnyl label also in cryptorchidism and hypogonadotropic hypogonadism in males.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Ovidrel, Pregnyl
Drug type
Recombinant protein
Targets
Luteinizing hormone/choriogonadotropin receptor (LHCGR)
Mechanism
Agonist of Luteinizing hormone/choriogonadotropin receptor (LHCGR)
Pathways
ovulation induction, final follicular maturation, early luteinization, testicular descent
Therapy area
Renal & urology
Developer
Organon Usa Llc (OGN)
FDA status
Approved as Ovidrel, Pregnyl (October 20, 1976), BLA017692 · FDA label
UNII
6413W06WR3

✅ FDA-approved uses

From the indications section of the FDA label (version of Dec 26, 2023). Read the full label for the exact wording, limitations and safety information.

Conditions studied

In Vitro FertilizationInfertility

Other drugs acting on LHCGR

More from Organon Usa Llc

Sources

Updated Oct 25, 2026. Something wrong or missing? Report it on the OGN page.

Follow OGN, the company behind Choriogonadotropin Alfa

See OGN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

OGN catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.